Ibrutinib and Rituximab Compared With Fludarabine Phosphate, Cyclophosphamide, and Rituximab in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
Clinical trial NCT02048813 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02048813
- Sponsor
- National Cancer Institute (NCI)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-03-10
- Primary completion
- 2018-10-24
- Enrollment
- 529
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.